New tests of a recently approved vaccine for respiratory syncytial virus—RSV—show the shot remains effective against a range of variants producing potent antibody responses against current and past strains, and may even ...
Messenger RNA (mRNA) technology has become popular in the last few years due to its use in COVID-19 vaccines. This technology has been so groundbreaking that it recently won the 2023 Nobel Prize in medicine "for discoveries ...
14 hours ago
0
10
Altered measles and mumps viruses could be used as a platform to create a trivalent COVID-19 vaccine that triggers immunity to multiple variant strains of the SARS-CoV-2 virus, new research in animals suggests.
Oct 2, 2023
0
21
Research by the Norwegian Institute of Public Health, Norway, suggests that COVID-19 vaccines or the body's response to them can lead to unexpected vaginal bleeding in women. This phenomenon was observed in women across different ...
Researchers at Karolinska Institutet who studied SARS-CoV-2 variant BA.2.86, found that the new variant was not significantly more resistant to antibodies than several other variants that are circulating. The study also showed ...
Oct 2, 2023
0
30
Researchers from the University of Pittsburgh and the National Institutes of Health (NIH) Vaccine Research Center have developed an improved way to test potential vaccines against bird flu. The report was published this week ...
Sep 29, 2023
0
29
From developing a one-and-done coronavirus shot to overcoming misinformation and global vaccine inequity, Nobel prize winner Drew Weissman says that at 64, he's only "speeding up."
Oct 2, 2023
0
3
The World Health Organization authorized a second malaria vaccine on Monday, a decision that could offer countries a cheaper and a more readily available option than the world's first shot against the parasitic disease.
Oct 2, 2023
0
10
The coronavirus pandemic brought global renown to the mRNA technology that underpins vaccines from Pfizer/BioNTech and Moderna, and on Monday earned a Nobel Prize for two scientists who have been key to its development.
Oct 2, 2023
0
80
Hungarian-born scientist Katalin Kariko's obsession with researching a substance called mRNA to fight disease once cost her a faculty position at a prestigious US university, which dismissed the idea as a dead end.
Oct 2, 2023
0
46
